Page last updated: 2024-10-30

losartan and Oliguria

losartan has been researched along with Oliguria in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Oliguria: Decreased URINE output that is below the normal range. Oliguria can be defined as urine output of less than or equal to 0.5 or 1 ml/kg/hr depending on the age.

Research Excerpts

ExcerptRelevanceReference
"To assess the role of the angiotensin receptor blocker losartan on the recoverability of renal function after de-obstruction in patients with anuria and oliguria."5.34Effect of losartan on the recoverability of renal function in anuric and oliguric patients with a solitary obstructed kidney: a double-blind randomized placebo-controlled trial. ( Elkappany, S; Elkarta, A; Hashem, A; Osman, Y; Sheashaa, H; Shokeir, AA, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Elkappany, S1
Hashem, A1
Elkarta, A1
Sheashaa, H1
Osman, Y1
Shokeir, AA1

Trials

1 trial available for losartan and Oliguria

ArticleYear
Effect of losartan on the recoverability of renal function in anuric and oliguric patients with a solitary obstructed kidney: a double-blind randomized placebo-controlled trial.
    BJU international, 2020, Volume: 126, Issue:6

    Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Anuria; Creatinine; Double-Blind Method; Femal

2020